It is difficult to work out the rationale for this.
What do not Advent simply raise the $3m themselves?
It seems BPH want the funds for their bio-tech.
It is a loan to Advent that BPH expect to receive back rather than purchasing more shares in Advent.
It seems BPH is using the PEP 11 opportunity/hype to raise more funds for their bio-tech because if PEP 11 is a failure then BPH may struggle to raise capital.
Also, it seems Breeze wishes to diversify or spread his risk in GBA and MMR in the event PEP 11 is a failure.
So what about the BPH bio-tech products. Are they tangible products or a long way from maturity?
GBA Price at posting:
25.0¢ Sentiment: None Disclosure: Held
